Tailoring IV antiplatelet therapy in chronic coronary syndromes

28 August 2026 (10:11 - 10:20)

Organised by:

Video

Sign in to view the resources

Slides

About the speaker

Associate Professor Francesco Pelliccia

Sapienza University of Rome, Rome (Italy)

4 More presentations in this session

Presentation thumbnail

Opening address

Doctor P. Capranzano (Catania, IT)

Presentation thumbnail

The acute coronary syndrome challenge: speed as a priority in PCI

Professor D. Angiolillo (Jacksonville, US)

Presentation thumbnail

The shock factor: optimising antiplatelet therapy

Associate Professor J. Siller-Matula (Vienna, AT)

Presentation thumbnail

Rapid power, precise control: the evolving role of intravenous P2Y12 inhibition in chronic coronary syndromes, acute coronary syndromes, and cardiogenic shock - discussion and Q&A

Access the full session

Session thumbnail

Rapid power, precise control: the evolving role of intravenous P2Y12 inhibition in chronic coronary syndromes, acute coronary syndromes, and cardiogenic shock

The Event

Event poster

ESC Congress 2026

28 August 2026 10:11 CET

You may be interested in

Congress Presentation

Antiplatelet agents for chronic coronary syndromes: which ones and for whom?

26 August 2022

Congress Presentation

Feasibility and outcomes of tailored antiplatelet therapy at a safety-net hospital

21 March 2026

Congress Presentation

Residual platelet activity and systemic inflammation in patients with chronic coronary syndrome in the context of aspirin monotherapy.

29 June 2021

Webinar

Personalised secondary prevention post-ACS: the role of biomarkers

13 October 2025

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources